PROGRAMMA - SIF

THURSDAY, October 15, 2009
P-1/2/7
P-1/2/8
P-1/2/9
P-1/2/10
P-1/2/11
P-1/2/12
P-1/2/13
INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN
CANCER CELLS
Simioni C., Merighi S., Gessi S., Varani K., Mirandola P.,
Leung E., Maclennan S., Baraldi P., Borea PA. (Ferrara,
Parma, Cary)
L163,255, A SYNTHETIC GROWTH HORMONE
SECRETAGOGUE, ALTERS CA 2+ HOMEOSTASIS AND
MODULATES CELL VIABILITY OF SKELETAL MUSCLE
Gramegna G., Liantonio A., Giannuzzi V., Conte Camerino
D. (Bari)
PERINATAL HYPOXIA IN NEONATAL AND ADULT BRAIN:
P2X7 ACTIVITY AND GLUTAMATE RELEASE
Barbieri R., Alloisio S., Cervetto C., Mazzotta M., Marcoli
M., Maura G., Nobile M. (Genoa)
ACTIVATION OF mGLU2/3 METABOTROPIC GLUTAMATE
RECEPTORS NEGATIVELY REGULATES THE STIMULATION
OF INOSITOL PHOSPHOLIPID HYDROLYSIS MEDIATED BY
5-HT2A SEROTONIN RECEPTORS IN THE FRONTAL CORTEX
OF LIVING MICE
Molinaro G., Traficante A., Riozzi B., Di Menna L., Curto
M., Pallottino S., Iacovelli L., Nicoletti F., Bruno V.,
Battaglia G. (Perugia, Rome, Pozzilli)
PRESYNAPTIC UROTENSIN RECEPTORS IN THE CERVICAL
SPINAL MOTONEURONS: FACILITATION OF
ACETYLCHOLINE RELEASE
Cervetto C., Mazzotta M., Bruzzone F., Diaspro A.,
Bianchini P., Vallarino M., Maura G., Leprince J., Vaudry
H., Marcoli M. (Genoa, Mont-Saint-Aignan)
C-TERMINAL DOMAIN REQUIREMENT FOR P2X7 RECEPTOR
TO FUNCTION AS A CHANNEL/PORE FOR GLUTAMATE
Mazzotta M., Cervetto C., Alloisio S., Nobile M., Maura G.,
Marcoli M. (Genoa)
SYNERGISTIC INHIBITION OF AGS GASTRIC CANCER CELL
GROWTH BY COMBINED TREATMENT WITH SMALL
MOLECULE RECEPTOR TYROSINE KINASE INHIBITORS
AND/OR PROTEASOME INHIBITORS
Damiano V., Troiani T., Piegari E., Russo R., Morgillo F.,
Martinelli E., Ciardello F., Rossi F., Berrino L. (Naples)
CYTOPLASMIC FES TYROSINE KINASE IS A DOWN-
STREAM EFFECTOR OF THE INSULIN-LIKE GROWTH
FACTORS (IGFS)/IGF-I RECEPTOR (IGF-IR) SYSTEM OF
NEUROBLASTOMA CELLS
Gnemmi I., Condorelli F., Canonico P. L. (Novara)
42
P-1/2/14
P-1/2/15
P-1/2/16
IN NEUROBLASTOMA CELL LINES, CYTOPLASMIC FES
TYROSINE KINASE LINKS THE INSULIN-LIKE GROWTH
FACTOR-I RECEPTOR (IGF-IR) ACTIVATION TO STAT3-
DEPENDENT ANTI-APOPTOTIC EFFECTS
Sanzone S., Condorelli F., Canonico P. L. (Novara)
CHARACTERIZATION OF THE ENZYME RESPONSIBLE FOR
THE DEGRADATION OF THE SECOND MESSENGER NAADP
Grolla A., Travelli C., Polzonetti V., Del Grosso E.,
Billington R., Canonico P. L., Genazzani A. (Novara,
Plymouth)
A GENOME-SCALE RNAI SCREEN IDENTIFIES EFFECTORS
OF FLT3-ITD IN ACUTE MYELOID LEUKEMIA
Caldarelli A., Paskow-Rozas M., Mueller J., Koch S.,
Kittler R., Genazzani A., Canonico P. L., Ding L., Kasper S.,
Fisher T., Boehmer F., Buchholz F. (Novara, Dresden,
Jena, Magdeburg)
43
THURSDAY, October 15, 2009